Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;76:861-870

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niroomand, F.
Right arrow Articles by Rauch, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niroomand, F.
Right arrow Articles by Rauch, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBACHOL CHLORIDE
Medline Plus Health Information
*Cardiomyopathy
(Circulation Research. 1995;76:861-870.)
© 1995 American Heart Association, Inc.


Articles

Impaired Function of Inhibitory G Proteins During Acute Myocardial Ischemia of Canine Hearts and Its Reversal During Reperfusion and a Second Period of Ischemia

Possible Implications for the Protective Mechanism of Ischemic Preconditioning

Presented in part at the 63rd to 66th Scientific Sessions of the American Heart Association (1990-1993).

Feraydoon Niroomand, Christof Weinbrenner, Angelika Weis, Matthias Bangert, Carsten Schwencke, Rainer Marquetant, Thorsten Beyer, Ruth H. Strasser, Wolfgang Kübler, Bernhard Rauch

From the Department of Cardiology, University of Heidelberg (Germany).

Correspondence to Dr Feraydoon Niroomand, Universität Heidelberg, Innere Medizin III, Bergheimerstr 58, 69115 Heidelberg, Germany.

Abstract A brief antecedent period of myocardial ischemia and reperfusion can delay cellular injury during a subsequent ischemic condition. Recent observations suggest that this protective mechanism depends on the continued activation of adenosine A1 receptors and Gi proteins. During acute myocardial ischemia, sufficient amounts of adenosine for maximal activation of adenosine A1 receptors are released, independent of a preconditioning ischemia. Hence, the protective mechanism of ischemic preconditioning may not exclusively be explained by activation of adenosine A1 receptors. As a working hypothesis, an increased responsiveness of Gi proteins toward receptor-mediated activation, leading to an increased response of Gi-regulated effectors, was tested in this study. In 47 anesthetized dogs, ischemia was induced by proximal ligation of the left anterior descending coronary artery. Animals underwent either a single period of 5 minutes of ischemia (n=9), a single period of 15 minutes of ischemia (n=10), 5 minutes of ischemia followed by 15 minutes of reperfusion (n=8), 15 minutes of ischemia followed by 60 minutes of reperfusion (n=5), or 5 minutes of ischemia followed by 15 minutes of reperfusion and a second period of 5 minutes of ischemia (n=15). Sarcolemmal membranes were prepared from the central ischemic area and from the posterior left ventricular wall, which served as the control. During ischemia, carbachol-stimulated GTPase decreased by 38% (control, 33.5±17.7; ischemia, 24.2±15 pmol · min-1 · mg protein-1; n=9; P<.001). The decrease in carbachol-stimulated GTPase activity was associated with a 45% decrease in carbachol-mediated inhibition of adenylyl cyclase (control, 28.9±2.4% maximal inhibition; ischemia, 15.1±2.6% maximal inhibition; n=5; P<.001). Prolongation of the ischemic period to 15 minutes did not lead to a further reduction of the Gi-mediated signal transduction. The binding properties of muscarinic receptors were not affected by ischemia. Furthermore, as demonstrated by carbachol-stimulated binding of [{gamma}-35S]GTP to sarcolemmal membranes, high- and low-affinity binding sites for the muscarinic antagonist carbachol, the EC50 for carbachol-stimulated GTPase activity and the substrate dependency of the high-affinity GTPase, the interaction between muscarinic receptors and inhibitory G proteins, and GTP binding to G proteins were not altered (n=14). Immunoblotting with {alpha}i- and {alpha}i2-specific antibodies did not indicate a loss of Gi proteins during ischemia that could explain the reduced GTPase activity. During 15 minutes of reperfusion, carbachol-stimulated GTPase activity increased to 147% of the control value (control, 33.7±20.6; reperfusion, 49.1±22.5 pmol · min-1 · mg protein-1; n=7; P=.012). Maximal inhibition of adenylyl cyclase by carbachol increased similarly (control, 21±6.8% maximal inhibition; reperfusion, 26.4±7.6% maximal inhibition; n=8; P=.016). After 15 minutes of ischemia and 60 minutes of reperfusion, carbachol-stimulated GTPase activity remained increased. When the 5-minute ischemia and 15-minute reperfusion periods were followed by a second period of 5-minute ischemia, carbachol-stimulated GTPase activity and inhibition of adenylyl cyclase remained elevated (GTPase: control, 38.4±16.7; second ischemia, 49.2±20.1 pmol · min-1 · mg protein-1; n=13; P=.009; adenylyl cyclase: control, 24.2±6.8% maximal inhibition; second ischemia, 28.6±8% maximal inhibition; n=15; P=.003). In conclusion, the responsiveness of Gi proteins toward receptor activation decreased rapidly during the first 5 minutes of ischemia. During a following 15-minute period of reperfusion, this decreased responsiveness was reversed completely, exceeding control activities. The increased responsiveness of this signaling pathway was maintained during a subsequent second ischemic period. This suggests that the underlying mechanism of ischemic preconditioning is the increased responsiveness of Gi proteins after a brief period of ischemia and reperfusion.


Key Words: myocardial ischemia • reperfusion • ischemic preconditioning • G proteins • muscarinic receptors • adenylyl cyclase




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. Tommasi, E. Carluccio, M. Bentivoglio, L. Corea, and E. Picano
Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: A double-blind, placebo controlled crossover stress echocardiographic study
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 83 - 88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. J. Schultz, A. K. Hsu, J. T. Barbieri, P.-L. Li, and G. J. Gross
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H495 - H500.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Domenech, P. Macho, D. Velez, G. Sanchez, X. Liu, and N. Dhalla
Tachycardia Preconditions Infarct Size in Dogs : Role of Adenosine and Protein Kinase C
Circulation, March 3, 1998; 97(8): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Mizumura, J. A. Auchampach, J. Linden, R. F. Bruns, and G. J. Gross
PD 81,723, an Allosteric Enhancer of the A1 Adenosine Receptor, Lowers the Threshold for Ischemic Preconditioning in Dogs
Circ. Res., September 1, 1996; 79(3): 415 - 423.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Miyawaki, X. Zhou, and M. Ashraf
Calcium Preconditioning Elicits Strong Protection Against Ischemic Injury via Protein Kinase C Signaling Pathway
Circ. Res., July 1, 1996; 79(1): 137 - 146.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R. Sandhu, U. Thomas, R. J. Diaz, and G. J. Wilson
Effect of Ischemic Preconditioning of the Myocardium on cAMP
Circ. Res., January 1, 1996; 78(1): 137 - 147.
[Abstract] [Full Text]